Skip to main content
eScholarship
Open Access Publications from the University of California

Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod

  • Author(s): Wills, Abby
  • Fan, Guang
  • Kim, Edward
  • Okada, Craig Y
  • White, Kevin P
  • Hopkins, R Samuel
  • et al.
Creative Commons 'BY-NC-ND' version 4.0 license
Abstract

A 55-year-old man with relapsing-remitting multiple sclerosis on fingolimod presented to the dermatology clinic with skin lesions on the left temple and cheek. Histopathology showed a diffuse infiltrate of enlarged, atypical lymphocytes throughout the dermis with an overlying grenz zone and a subpopulation of scattered smaller lymphocytes and plasma cells. Epstein-Barr virus-encoded RNA in situ hybridization stain was positive. Based on the morphologic and immunophenotypic findings, a diagnosis of EBV-positive diffuse large B-cell lymphoma was made. This case aims to raise awareness for the dermatologist that patients on fingolimod may be at increased risk of lymphoproliferative disorders.

Main Content
Current View